Comparison of oxaliplatin‐ and curcumin‐mediated antiproliferative effects in colorectal cell lines

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.22645PMID 17330230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Using chemopreventive agents to enhance the efficacy of cancer therapy.

  2006cited by this paper
• Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1

  2006cited by this paper
• Inhibition of Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Is Not Sufficient to Account for Indole-3-Carbinol–Induced Apoptosis in Some Breast and Prostate Tumor Cells

  2005cited by this paper
• Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.

  2005cited by this paper
• Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.

  2005cited by this paper
• Chemopreventive properties of curcumin.

  2005cited by this paper
• Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.

  2005cited by this paper
• Curcumin: Getting Back to the Roots

  2005cited by this paper
• Curcumin: the story so far.

  2005cited by this paper
• Chemopreventive and therapeutic effects of curcumin.

  2005cited by this paper
• Systemic therapy for metastatic colorectal cancer: current options, current evidence.

  2005cited by this paper
• Preclinical Evaluation of ZD1839 Alone or in Combination with Oxaliplatin in a Panel of Human Tumor Cell Lines – Implications for Clinical Use

  2005cited by this paper
• Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells

  2005cited by this paper
• Prospects for plant-derived chemopreventive agents exhibiting multiple mechanisms of action.

  2005cited by this paper
• Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

  2004cited by this paper
• Cell death by mitotic catastrophe: a molecular definition

  2004cited by this paper
• Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.

  2004cited by this paper
• Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA

  2004cited by this paper
• Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy

  2004cited by this paper
• Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.

  2003cited by this paper
• DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells.

  2003cited by this paper
• Characterization of sequence-dependent synergy between ZD1839 ("Iressa") and oxaliplatin.

  2003cited by this paper
• Editorial: Looking Beyond the Obvious

  2002cited by this paper
• Cellular and molecular pharmacology of oxaliplatin.

  2002cited by this paper
• Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.

  2002cited by this paper
• Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.

  2002cited by this paper
• Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

  2001cited by this paper
• Regulation of the G2/M transition by p53

  2001cited by this paper
• Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells.

  2001cited by this paper
• Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

  2001cited by this paper
• Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.

  2000cited by this paper
• Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

  2000cited by this paper
• Clinical pharmacokinetics of oxaliplatin: a critical review.

  2000cited by this paper
• Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

  2000cited by this paper
• Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex

  1999cited by this paper
• Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage

  1998cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.

  1996cited by this paper
• Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].

  1995cited by this paper
• Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*)

  1995cited by this paper

• Curcumin in colorectal cancer: preventive strategies and therapeutic mechanisms

  2025cites this paper
• Anticancer Activity of Roburic Acid: In Vitro and In Silico Investigation

  2025influential citation
• Sprayed hyaluronic acid based multidrug composite hydrogel for postoperative colorectal cancer ultra-efficient long-lasting multi-stage immuno-chemo synergistic therapy.

  2025cites this paper
• A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer

  2024cites this paper
• Integrins as the pivotal regulators of cisplatin response in tumor cells

  2024cites this paper
• Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy

  2024cites this paper
• Co-delivery Liposomes of Irinotecan Hydrochloride and Curcumin in the Synergistic Treatment of Colorectal Cancer

  2024cites this paper
• Natural Polyphenols in Cancer Management: Promising Role, Mechanisms, and Chemistry.

  2023cites this paper
• Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.

  2023cites this paper
• Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy

  2023cites this paper
• Combination of oxaliplatin and β-carotene suppresses colorectal cancer by regulating cell cycle, apoptosis, and cancer stemness in vitro

  2023cites this paper
• Modulatory effect of myricitrin against chromosome instability and cytostasis induced by bleomycin and oxaliplatin in CHO-K1 cells

  2022cites this paper
• Determination of Oxaliplatin and Curcumin in Combination via Micellar HPLC and Its Method Validation.

  2022cites this paper
• A concise review on the role of natural and synthetically derived peptides involved in colorectal cancer.

  2022cites this paper
• Is Curcumin at the Threshold of Therapeutic Effectiveness on Patients with Colon Cancer?—A Systematic Review

  2021cites this paper
• L-amino acid oxidase from snake venom: Biotransformation and induction of apoptosis in human colon cancer cells.

  2021cites this paper
• Focus on Multi-targeted Role of Curcumin: a Boon in Therapeutic Paradigm

  2021cites this paper
• Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

  2021cites this paper
• Curcuma as an adjuvant in colorectal cancer treatment.

  2021cites this paper
• Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers

  2021cites this paper
• Polyphenols and cancer

  2021cites this paper
• Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5‐fluorouracil in vivo by increasing curcumin bioavailability

  2021cites this paper
• Glucosinolate-rich hydrolyzed extract from Moringa oleifera leaves decreased the production of TNF-α and IL-1β cytokines and induced ROS and apoptosis in human colon cancer cells

  2020cites this paper
• Design of new improved curcumin derivatives to multi-targets of cancer and inflammation.

  2020cites this paper
• The Role of Nutrition in Integrative Oncology

  2020cites this paper
• Pro-Inflammatory Effects of NX-3 Toxin Are Comparable to Deoxynivalenol and not Modulated by the Co-Occurring Pro-Oxidant Aurofusarin

  2020cites this paper
• Synergistic anticancer effects of curcumin and 3',4'-didemethylnobiletin in combination on colon cancer cells.

  2020cites this paper
• Curcumin: A therapeutic strategy for colorectal cancer?

  2020cites this paper
• Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state‐of‐the‐art

  2019cites this paper
• Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial

  2019cites this paper
• Courier properties of modified citrus pectinate-chitosan nanoparticles in colon delivery of curcumin

  2019cites this paper
• Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats

  2019cites this paper
• Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers

  2019cites this paper
• Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.

  2019cites this paper
• Metal Drugs and the Anticancer Immune Response.

  2018cites this paper
• Curcumin-induced promoter hypermethylation of the mammalian target of rapamycin gene in multiple myeloma cells

  2018cites this paper
• The Immunomodulatory and Anti-Inflammatory Role of Polyphenols

  2018cites this paper
• Combination Regimens Using Dietary Components For The Chemoprevention Of Colorectal Cancer

  2018cites this paper
• The Role of Curcumin in Prevention and Management of Metastatic Disease

  2018cites this paper
• Selection and optimization of nano‐formulation of P‐glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells

  2017cites this paper
• Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway

  2017cites this paper
• Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

  2017cites this paper
• Selective mechanism of action of dietary peptides from common bean on HCT116 human colorectal cancer cells through loss of mitochondrial membrane potential and DNA damage

  2016cites this paper
• Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

  2016cites this paper
• Estudi de l'efecte de la curcumina en la reversió de la resistència adquirida a oxaliplatí mitjançant la inhibició de la via de senyalització de NF-kB en models cel·lulars de càncer colorectal

  2016influential citation
• Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

  2016cites this paper
• Influence of serum albumin on intracellular delivery of drug-loaded hyaluronan polymeric micelles.

  2016cites this paper
• Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.

  2016cites this paper
• Diamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo Model

  2016cites this paper
• Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

  2015cites this paper
• Treatment of metastatic colorectal cancer : a role for curcumin?

  2015cites this paper
• The Multifaceted Role of Curcumin in Cancer Prevention and Treatment

  2015cites this paper
• Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin

  2015cites this paper
• Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1

  2014cites this paper
• Curcumin in combined cancer therapy.

  2014cites this paper
• Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest

  2014cites this paper
• Curcumin -Role in Cancer

  2014cites this paper
• The role of cancer stem cells in the anti-carcinogenicity of curcumin.

  2013cites this paper
• Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C.

  2013cites this paper
• Pharmacology of phytochemicals

  2013cites this paper
• Perifosine sensitizes curcumin‐induced anti‐colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro

  2012cites this paper
• Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.

  2012cites this paper
• Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury

  2012cites this paper
• The Notch pathway as a biomarker in pancreatic ductal adenocarcinoma and its potential therapeutic modulation

  2012cites this paper
• For Peer Review Curcumin-induced mitotic arrest is characterised by spindle abnormalities, defects in chromosomal congression and DNA damage

  2012cites this paper
• Frontiers in Research: Herbal Bioactive Molecules: The Hidden Jewels for Drug Development Discovery of curcumin, a component of golden spice, and its miraculous biological activities

  2012cites this paper
• Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage

  2012cites this paper
• Epigenetic mechanisms of plant-derived anticancer drugs.

  2012cites this paper
• Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo

  2011cites this paper
• Best Practice & Research Clinical Gastroenterology

  2011cites this paper
• Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

  2011cites this paper
• Antiproliferative effects of Curcumin plus Centchroman in MCF-7 and MDA MB-231 cells

  2011cites this paper
• Therapeutic potential of curcumin in gastrointestinal diseases.

  2011cites this paper
• Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice.

  2011cites this paper
• Curcumin enhances dasatinib‐induced inhibition of growth and transformation of colon cancer cells

  2011influential citation
• Curcumin: the potential for efficacy in gastrointestinal diseases.

  2011cites this paper
• Curcumin-induced G2/M cell cycle arrest in colorectal cancer cells

  2011influential citation
• Novel aspects for the application of Curcumin in chemoprevention of various cancers.

  2010cites this paper
• Mechanisms Associated with the Chemotherapeutic Effects of Zyflamend, a Multi-Herbal Extract, on Advanced Prostate Cancer

  2010cites this paper
• Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs

  2010cites this paper
• Review article PHARMACOTHERAPEUTICS OF CURCUMA LONGA- A POTENT PATENT

  2010cites this paper
• PHARMACOTHERAPEUTICS OF CURCUMA LONGA- A POTENT PATENT

  2010cites this paper
• Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice

  2010cites this paper
• Flavonoids and age-related disease: risk, benefits and critical windows.

  2010cites this paper
• Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment

  2010cites this paper
• The role of hypoxia in colon cancer cell resistance to cytotoxic antitumour agents and modulation of Hypoxia-inducible factor-1 as a strategy to circumvent chemoresistance

  2009cites this paper
• Dietary Chemopreventive Phytochemicals: Too Little or Too Much?

  2009cites this paper
• Curcumin induces apoptosis-independent death in oesophageal cancer cells

  2009cites this paper
• Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29.

  2009cites this paper
• Overcoming Drug Resistance by Phytochemicals

  2009cites this paper
• Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro

  2008cites this paper
• Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.

  2008cites this paper
• Indole-3-carbinol enhances antiproliferative , but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines

  2008cites this paper
• Apoptotic Induction with Bifunctional E.coli Cytosine Deaminase-Uracil Phosphoribosyltransferase Mediated Suicide Gene Therapy is Synergized by Curcumin Treatment In vitro

  2008cites this paper
• Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines.

  2008cites this paper
• Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.

  2008cites this paper
• Irinotecan versus oxaliplatin for adjuvant colon cancer therapy: Why do the results differ?

  2008cites this paper
• Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research.

  2008cites this paper
• Curcumin and cancer: an "old-age" disease with an "age-old" solution.

  2008cites this paper
• Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.

  2008influential citation